Summary: The containment, regulation, or restraint of costs. Costs are said to be contained when the value of resources committed to an activity is not considered excessive. This determination is frequently subjective and dependent upon the specific geographic area of the activity being measured. (From Dictionary of Health Services Management, 2d ed)
Publications273 found, 100 shown here
- Cancer care, money, and the value of life: whose justice? Which rationality?Daniel P Sulmasy
The John J Conley Department of Ethics, St Vincent s Hospital Manhattan and New York Medical College, New York, NY 10011, USA
J Clin Oncol 25:217-22. 2007..Oncologists would then be free to advocate for their patients within the constraints imposed by this public process...
- Contrary to cost-shift theory, lower Medicare hospital payment rates for inpatient care lead to lower private payment ratesChapin White
Center for Studying Health System Change, Washington, DC, USA
Health Aff (Millwood) 32:935-43. 2013..My findings indicate that repealing cuts in Medicare payment rates would not slow the growth in spending on hospital care by private insurers and would in fact be likely to accelerate the growth in private insurers' costs and premiums...
- Medicaid cost control measures aimed at second-generation antipsychotics led to less use of all antipsychoticsWilliam B Vogt
Terry College of Business, University of Georgia, Athens, GA, USA
Health Aff (Millwood) 30:2346-54. 2011..Comparative effectiveness research should guide physicians and health plans on appropriate first treatments, while prior authorization policies should focus on moving patients to appropriate second-line therapies when necessary...
- Pharmaceutical cost control in Canada: does it work?D Menon
Institute of Health Economics, and University of Alberta, Edmonton
Health Aff (Millwood) 20:92-103. 2001..Total drug spending in the country continues to rise, however; clearly, mechanisms other than price controls will need to be developed if drug spending is to be better managed...
- Whither seniors' pharmacare: lessons from (and for) CanadaSteven G Morgan
Centre for Health Services and Policy Research, University of British Columbia
Health Aff (Millwood) 22:49-59. 2003..Sustainable and equitable pharmacare programs require the political willingness to confront opposition to policies that will, if successful, contain program costs without obstructing access...
- Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilizationSebastian Schneeweiss
Department of Epidemiology, Harvard School of Public Health, Boston, Mass, USA
CMAJ 166:737-45. 2002..The objective of this study was to analyze the effect of reference-based pricing of angiotensin-converting enzyme (ACE) inhibitors on drug utilization, cost savings and potential substitution with other medication classes...
- [Assessment of the pharmaceutical expenditure in Hungary]András Inotai
Semmelweis Egyetem, Egyetemi Gyógyszertár Gyógyszerügyi Szervezési Intézet, Budapest, Hogyes E u 9 1092
Acta Pharm Hung 80:162-72. 2010..In order to improve the allocative efficiency of health care spending, available resources should be spent only on effective, cost-effective, economically affordable medicines...
- Attitudes toward managed care and cost containment among primary care trainees at 3 training sitesS A Skootsky
Office of Education, Development and Research, School of Medicine, University of California, UCLA Medical Plaza, Los Angeles, CA 90095, USA
Am J Manag Care 5:1397-404. 1999....
- Group purchasing of pharmaceuticals and medical supplies by the Gulf Cooperation Council statesT A M Khoja
Executive Office of the GCC States for Health Ministers, Riyadh, Saudi Arabia
East Mediterr Health J 11:217-25. 2005..It also discusses the future of the group purchasing programme in the light of globalization and how the international changes under the World Trade Organization agreements will affect the programme in future...
- Does therapeutic reference pricing always result in cost-containment? The Hungarian evidenceZoltan Kalo
Novartis Hungary Ltd, Budapest, Hungary
Health Policy 80:402-12. 2007..Based upon the first experiences of the Hungarian implementation, the method described in this paper for the extension of generic reference pricing to therapeutic categories is not justifiable...
- [Pharmaceutical reference pricing in Germany: definition of therapeutic groups, price setting through regression procedure and effects]T Stargardt
Technische Universitat Berlin, Fachgebiet Management im Gesundheitswesen
Gesundheitswesen 67:468-77. 2005..Nevertheless, compared to other instruments of price-regulation, reference pricing seems to be a good alternative to control pharmaceutical prices, since rationing is kept as little as possible...
- Current national initiatives about drug policies and cost control in Europe: the Italy exampleFrancesca Rocchi
Direzione Generale sui Farmaci e Dispositivi Medici Ministerio della Salute, Rome, Italy
J Ambul Care Manage 27:127-31. 2004..The set of interventions yielded a new national formulary that was able to have a significant influence on the trend of drug expenditure in Italy. This experience can be a useful reference for other European and non-European states...
- [Incentives in primary care from cost containment to public health]Juan Gervas
Rev Esp Salud Publica 81:589-96. 2007
- A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribingHelen Prosser
Prescribing Research Group, Department of Pharmacology and Therapeutics, The Infirmary, 70 Pembroke Place, Liverpool L69 3GF, UK
Soc Sci Med 60:1335-46. 2005..GPs largely applied simple cost-minimization while cost-consideration was undermined by contextual factors. Implications for research and policy are discussed...
- European healthcare policies for controlling drug expenditureSilvia M Ess
Hirslanden Research, Zurich, Switzerland
Pharmacoeconomics 21:89-103. 2003..Policies intended to affect physicians' prescribing behaviour include guidelines, information (about price and less expensive alternatives) and feedback, and the use of budgetary restrictions...
- Physicians' views on resource availability and equity in four European health care systemsSamia A Hurst
Institute for Biomedical Ethics, Geneva University Medical School, Switzerland
BMC Health Serv Res 7:137. 2007..The perception of physicians, who witness the effects of these strategies, may provide useful insights regarding the impact of system-wide priority setting on access to care...
- Seniors' prescription drug cost inflation and cost containment: evidence from British ColumbiaSteven G Morgan
Centre for Health Services and Policy Research, University of British Columbia, 429 2194 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3
Health Policy 68:299-307. 2004..Changes in the mix of therapies and the type of product selected explained over half of the observed drug expenditure inflation. Increased generic substitution significantly reduced the price of products selected over the period...
- Managing oncology costsClaiborne E Reeder
University of South Carolina College of Pharmacy, 715 Sumter Street, Coker Life Sciences Bldg, Room 109, Columbia, SC 29208, USA
Am J Manag Care 12:S3-16; quiz S17-9. 2006This monograph will review the burden of illness in oncology, suggest a framework for evaluating oncology costs and consequences, identify economic modeling formats in cancer care, and explore methods of cost control for cancer care.
- Proposal of the Physicians' Working Group for Single-Payer National Health InsuranceSteffie Woolhandler
Department of Medicine, Cambridge Hospital Harvard Medical School, Cambridge, Mass 02139, USA
JAMA 290:798-805. 2003..An NHI program is the only affordable option for universal, comprehensive coverage...
- Perceptions of cost constraints, resource limitations, and rationing in United States intensive care units: results of a national surveyNicholas S Ward
Division of Pulmonary Critical Care, Brown Medical School, Providence, RI, USA
Crit Care Med 36:471-6. 2008..To examine cost constraints, resource limitations, and rationing within U.S. intensive care units (ICUs) as perceived by ICU clinicians and the roles of ICU physician and nurse directors in resource allocation decisions...
- Surgeon-led initiatives cut costs and enhance the quality of endoscopic and laparoscopic proceduresJeff W Allen
Department of Surgery, University of Louisville School of Medicine, Center for Advanced Surgical Technologies of Norton Hospital, Louisville, Kentucky 40292, USA
JSLS 7:243-7. 2003Public perception depicts surgical cost control and quality of care as polar opposites...
- Disease burden profiles: an emerging tool for managing managed careYang Zhao
DxCG, Inc, Boston, MA 02111, USA
Health Care Manag Sci 5:211-9. 2002..We also examine and compare the predictive power of claims-based models within a diabetic cohort...
- Absence of appropriate hospitalization cost control for patients with medical insurance: a comparative analysis studyXilong Pan
Peking University Health Science Center, Health Policy and Management Department, School of Public Health, Beijing, People s Republic of China
Health Econ 18:1146-62. 2009..Expose the weak loops in the Chinese medical insurance coverage and uncover hospitals' role of over-pricing hospitalized insured patients compared with those non-insured...
- The importance of understanding the costs of critical care and mechanical ventilationDale M Needham
Crit Care Med 33:1434-5. 2005
- Practicing surgeons lead in quality care, safety, and cost controlEugene H Shively
Department of Surgery, University of Louisville School of Medicine and Quality Surgical Solutions, PLLC, Louisville, KY, USA
Ann Surg 239:752-60; discussion 760-2. 2004..To report the experiences of 66 surgical specialists from 15 different hospitals who performed 43 CPT-based procedures more than 16,000 times...
- Issues in the acquisition, development, and use of technology in health careRaymond J Lanzafame
Via Health, Rochester General Hospital, Rochester, New York, USA
JSLS 10:401-8. 2006
- Decentralized responsibility for costs of outpatient prescription pharmaceuticals in Sweden. Assessment of models for decentralized financing of subsidies from a management perspectiveGina Bergström
Department of Social Medicine, Sahlgrenska Academy at Goteborg University, SE 405 30 Goteborg, Sweden
Health Policy 81:358-67. 2007..Experiences from other reforms in health care support this hypothesis. This means that there is a risk that cost containment jeopardises medical decisions on patient level...
- Reducing waste of intravenous solutionsL D Diehl
Tripler Army Medical Center, Honolulu, HI
Am J Hosp Pharm 49:106-8. 1992..By using several methods to reduce the waste of i.v. solutions, a pharmacy department has limited the rate of waste to only 3.27%...
- Physicians' ethical beliefs about cost-control arrangementsD P Sulmasy
The John J Conley Department of Ethics, St Vincents Hospital, New York, NY 10011, USA
Arch Intern Med 160:649-57. 2000..Although much has been written about the ethics of new methods of health care financing, little is known about the extent to which physicians experience these cost-control arrangements as ethical problems...
- The cost escalation of social health insurance plans in China: its implication for public policyX Liu
Department of Social Medicine, Shandong Medical University, Jinan, People s Republic of China
Soc Sci Med 41:1095-101. 1995..4% between 1985-1989. Chinese experience also shows that demand strategy (co-payment by patients) had very little effect to contain cost escalation...
- Health care as a fixed-cost industry: implications for deliveryPaul A Taheri
Center for Health Care Economics, University of Michigan, Ann Arbor, MI 48109, USA
Surg Innov 12:365-71. 2005..Elements include flexing intensive care unit beds, improving operating room efficiencies, and rationalizing health care capacity...
- Patients' attitudes toward cost control bonuses for managed care physiciansT H Gallagher
Division of General Medical Sciences, Department of Medicine, Washington University School of Medicine, St. Louis, USA
Health Aff (Millwood) 20:186-92. 2001..To understand how patients view these incentives, we interviewed 1,050 patients regarding a 10 percent cost control bonus and a combined cost control/quality bonus...
- Moving beyond the drug budget silo mentality in EuropeMichael Drummond
Centre for Health Economics, University of York, York, UK
Value Health 6:S74-7. 2003
- Encourage all to keep costs down. We must take steps to return control of healthcare dollars, decisions to individualsRon Paul
United States House of Representatives, USA
Mod Healthc 37:22. 2007
- Controlling costs of critical care requires new focusZvi Herschman
Anesth Analg 97:607; author reply 607-8. 2003
- Why McCain has the best health-care planShawn Tully
Fortune 157:143-4, 146. 2008
- Drug-altered states. As pharmaceutical spending continues to soar, state legislatures are taking bold steps to rein in their costsJeff Tieman
Mod Healthc 32:28-31. 2002
- Mergers and health care organizationsDiana V Shaw
Brigham and Women s OBGYN Department, Harvard Medical School, USA
J Health Care Finance 29:28-37. 2003..It reviews issues raised by mergers and examines a few case studies of merged health care organizations...
- Using disease management and market reforms to address the adverse economic effects of drug budgets and price and reimbursement regulations in GermanyTim Schwermann
Center of Health Economics and Health System Research, University of Hannover, Hannover, Germany
Value Health 6:S20-30. 2003..Over the past decade, a number of specific budgeting initiatives were introduced to control drug spending-with some success, at least until the 11% increase in the first 6 months of 2001...
- Look beyond budgets to the broader benefitsRobert Dugal
Policy, Planning and Research, Rx and D, Ottawa
Healthc Pap 3:77-82; discussion 87-94. 2002..Patient health management is a strategy that deserves a closer look to achieve this goal...
- Pharmacy discount card programs: catching up with the health marketsDrew Edwards
Kenco Insurance Agency, Louisville, Kentucky, USA
Empl Benefits J 27:42-3. 2002..Pharmacy costs continue to rise, as does the number of senior citizens. One of the ways of containing costs may be the pharmacy discount drug card program, for both seniors and the general population...
- Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patientsChien Wen Tseng
Department of Family Practice and Community Health, University of Hawaii, and Pacific Health Research Institute, Honolulu, USA
JAMA 290:222-7. 2003..Annual dollar limits, or "caps," on drug benefits are common in Medicare managed care (Medicare + Choice) and have been part of several proposals for a national Medicare drug benefit...
- The drug budget silo mentality: the French caseClaude Le Pen
University of Paris Dauphine, Paris, France
Value Health 6:S10-9. 2003....
- Managing in the "new" era of managed careMichael Alper
Meridian Healthcare Management, Woodland Hills, CA, USA
Manag Care Q 10:24-9. 2002....
- Access to affordable medications: the Department of Veterans Affairs pharmacy plan as a national modelChester B Good
Am J Public Health 97:2129-31. 2007
- The "R" wordM Gregg Bloche
Georgetown University Law Center, USA
J Contemp Health Law Policy 18:633-9. 2002
- Components of spending for Medicaid Mental Health Services, 2001Tami L Mark
Medstat, Washington, DC, USA
Psychiatr Serv 56:648. 2005
- Managed competition using both market-driven and regulatory strategiesThomas P Weil
Health and Hospital Service, Asheville, NC, USA
Manag Care Q 10:32-40. 2002....
- The impact of a national prescription drug formulary on prices, market share, and spending: lessons for Medicare?Haiden A Huskamp
Department of Health Care Policy, Harvard Medical School, USA
Health Aff (Millwood) 22:149-58. 2003..We find that the VHA National Formulary was effective at shifting prescribing behavior toward the selected drugs, achieving sizable price reductions from manufacturers, and greatly decreasing drug spending...
- Getting the cat back in the bag: reforming the way provinces manage drug expenditures to make them manageableAdrian R Levy
Centre for Health Evaluation and Outcome Sciences, St Paul s Hospital, Department of Health Care and Epidemiology, University of British Columbia, Vancouver
Healthc Pap 3:32-7; discussion 87-94. 2002..The question of how to implement the recommendations remains to be elucidated, as does an evaluation of the trade-offs between costs and benefits of obtaining better information on cost-effectiveness...
- More of the same is not enoughDonald J Willison
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario
Healthc Pap 3:47-55; discussion 87-94. 2002..Better evidence and better dissemination are simply not enough...
- AOA Symposium. Gainsharing in orthopaedics: passing fancy or wave of the future?Douglas R Dirschl
Department of Orthopaedics, University of North Carolina, Chapel Hill, NC 27599 7055, USA
J Bone Joint Surg Am 89:2075-83. 2007
- Andrew Webber: a champion for value-driven health careAndrew Webber
Healthc Financ Manage 61:30-2, 34. 2007
- Rx for Medicaid: with Medicaid costs rising and revenues declining, states are looking at what to doLaura Tobler
State Legis 29:16-20. 2003
- The consumer-driven approach: can it pick up where managed care left off?Steve Halterman
Benefits Q 19:13-26. 2003..This article discusses the failure of managed care and ways that employers can promote consumer-driven behavior now using available tools and plan provisions...
- The drug budget silo mentality in Europe: an overviewLou Garrison
Health Economics and Strategic Pricing, Roche Pharmaceuticals, Basel, Switzerland Office of Health Economics, London, UK
Value Health 6:S1-9. 2003
- Pharmacy benefit management contracting: an assessment from a recent public sector procurement experienceJay P Bae
Department of Economics, Andrew Young School of Policy Studies, Georgia State University, USA
J Health Care Finance 29:49-56. 2002..Those who are considering contracting with a PBM will find the assessment of the PBM industry timely and informative...
- The sad history of health care cost containment as told in one chartDrew E Altman
Henry I Kaiser Family Foundation, Menlo Park, California, USA
Health Aff (Millwood) . 2002
- The economics of prescription drug prices, government intervention, and the importation of drugs from CanadaMatthew S Openshaw
Public Policy and Political Economy, University of Texas at Dallas, Dallas, TX, USA
Nurs Econ 23:307-11, 279. 2005..What effects would this have on consumer prices, drug companies' incentives, and the development of new medications?..
- New York Medicaid: never can say goodbyeJoseph Fastiggi
Cornell J Law Public Policy 16:581-615. 2007
- Australian drugs scheme threatens free-trade talksDavid Fickling
Lancet 363:299. 2004
- Reference pricing of pharmaceuticals for Medicare: evidence from Germany, The Netherlands, and New ZealandPatricia M Danzon
University of Pennsylvania, USA
Front Health Policy Res 7:1-54. 2004..S. generic market, and on research and development (R&D) and the future supply of new drugs, because of the much larger U.S. share of global pharmaceutical sales...
- Managing healthcare costs within an integrated frameworkRudy Fernandes
Business Development and Market Access, Wyeth Ayerst Canada Inc
Healthc Pap 3:70-6; discussion 87-94. 2002..It is highly regarded for promoting effective treatment options, improving patient care and optimizing healthcare resource utilization--hence deserving serious consideration for reducing overall costs while achieving improved outcomes...
- Managing the cost of specialty pharmaceuticalsCatherine A Kernich
University Hospitals Health System, Cleveland, OH, USA
Nurs Econ 22:245-50, 227. 2004..This system includes working closely with providers and payers, underpinned with sound business planning techniques...
- How should we pay the piper when he's calling the tune? On the long-term affordability of cancer care in the United StatesScott D Ramsey
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
J Clin Oncol 25:175-9. 2007
- Medicaid: 10 fixes that work. Of all the reforms states have tried, these are the ones that hold the most promiseMartha King
State Legis 30:14-8. 2004
- A sustainable solutionMike Van Den Eynde
Life Sciences and Health Care Practice, Deloitte Consulting LLP, USA
AHIP Cover 47:36-8, 40-1. 2006
- Is a paradigm shift in US healthcare reimbursement inevitable?August M Watanabe
Guidant Corporation, Indianapolis, Ind, USA
Circulation 109:1456-9. 2004
- High prescription drug prices and the influence of the Food and Drug AdministrationGary W Lawson
Mayo Clin Proc 79:569; discussion 569-70. 2004
- Missouri Medicaid reform...what can physicians do?Larry W Halverson
Cox Family Practice Residency, Springfield, USA
Mo Med 103:102-5. 2006
- The humanizing of healthcare delivery. Tackling the high costs and closing the loopholesJohn Kerry
Healthc Leadersh Rep 12:4-12. 2004
- ["Antibiotic stewardship": catchword or necessity?]S Bassetti
Abteilung für Infektiologie, Bereich Innere Medizin, Kantonsspital Basel
Praxis (Bern 1994) 93:623-5. 2004
- Controlling U.S. health spending: opportunities for academic health centersGerard F Anderson
Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA
Acad Med 81:807-11. 2006....
- Impact of formulary restrictions on the cost-effectiveness of antidepressant treatmentDavid V Sheehan
Department of Psychiatry and Behavioral Medicine, University of South Florida College of Medicine, Tampa, FL, USA
Manag Care Q 10:21-31. 2002..Assessment of overall cost-effectiveness should not be limited by acquisition costs but should take total healthcare costs into consideration...
- Creating the next generation of medical managementDuncan Moore
McKinsey and Company, Chicago, USA
AHIP Cover 45:22-6, 28, 30. 2004
- Slowing the growth of health care costs--learning from international experienceKaren Davis
Commonwealth Fund, New York, USA
N Engl J Med 359:1751-5. 2008
- Shifting the focus from cost to value: an employer perspectivePamela A Hymel
Cisco Systems, 170 West Tasman Dr, Bldg 5 3, San Jose, CA 92886, USA
J Manag Care Pharm 12:S6-10; quiz S24-6. 2006..To review ways in which pharmacists can help health plans shift their focus from cost to value...
- Health care cost control. Getting on the right trackMick L Diede
Manag Care 11:24-5, 29-33. 2002
- The changing face of managed careDebra A Draper
Mathematica Policy Research, Washington, DC, USA
Health Aff (Millwood) 21:11-23. 2002..Consequently, purchasers and consumers face escalating health care costs under these changing conditions...
- The prescription-drug problemRobert Steinbrook
N Engl J Med 346:790. 2002
- Control of prescription costs--is it possible?Patrick N Renaud
Empl Benefits J 27:11-4. 2002..The author considers two choices for controlling the cost of prescription drugs: Return the prescription drug program to the TPA, or implement plan design changes. Making changes to the buying habits of the public is key...
- Expenditures for prescription drugs: too much or not enough?Glen T Schumock
College of Pharmacy, University of Illinois at Chicago, USA
Healthc Financ Manage 57:34-8, 41. 2003..Drug spending can be controlled by: Understanding the sources of drug cost Improving use of drug formularies Using clinical pharmacists to improve prescribing behavior...
- Save an arm and a legDavid Stires
Fortune 148:208, 210. 2003
- Living with GASB 45: how to manage liabilities associated with retiree medical benefitsFrank Thoen
Milliman, Inc, Seattle, USA
Benefits Q 24:39-45. 2008..Now is the time for employees and employers to work together and make difficult choices for keeping retiree medical costs and GASB 45 liabilities manageable...
- The impact of physician entrepreneurship on escalating health care costsThomas Fletcher
Austin Radiological Association, Austin, Texas 78746, USA
J Am Coll Radiol 2:411-4. 2005..This article explores the role of physician entrepreneurship in rising health care costs. Under the wrong circumstances, the invisible hand of the free market can become dysfunctional...
- Caveats of evaluating costs in critical careAlbert E Holt
Crit Care Med 32:299-300. 2004
- A critical review of cost reduction in neonatal intensive care. I. The structure of costsD K Richardson
Department of Neonatology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
J Perinatol 21:107-15. 2001....
- In a bundling era, finding a fair price for ESRD servicesJohn D Sullivan
Boston University, USA
Nephrol News Issues 21:37, 39-40. 2007
- Managing prescription drug costsJ M Sica
Aon Consulting, Conshohocken, Pennsylvania, USA
Empl Benefits J 26:35-40. 2001..The author also discusses pharmacy benefit managers, as well as various utilization management strategies like benefit plan design and the use of formularies...
- Why do FEHBP and big unions excel at managing drug costs?Tony Berberabe
Manag Care 12:36-9. 2003
- Reining in prescription drug costsNancy Burns
Remedi SeniorCare, USA
Provider 34:33-5. 2008
- Workers' compensation reformDouglas C D'Andrea
Division of Occupational and Environmental Medicine, Department of Medicine, University of Connecticut Health Center School of Medicine, 263 Farmington Avenue, Dowling North, Farmington, CT 06030 6210, USA
Clin Occup Environ Med 4:vi, 259-71. 2004..Future reform efforts will need to focus not only on the costs of the system but also its inclusiveness and support of the workers and their families it was intended to protect...
- Attitudes toward the autopsy--an 8-state surveyPeter N Nemetz
Strategy and Business Economics Division, Sauder School of Business, University of British Columbia, Vancouver, British Columbia, Canada
MedGenMed 8:80. 2006..National autopsy rates have declined for several decades, and the reasons for such decline remain contentious...
- Pursuing cost containment in a pluralistic payer environment: from the aftermath of Clinton's failure at health care reform to the Balanced Budget Act of 1997Rick Mayes
Department of Political Science, University of Richmond and Petris Centre on Health Care Markets and Consumer Welfare, University of California, Berkeley, CA, USA
Health Econ Policy Law 1:237-61. 2006..of President Clinton's attempt at comprehensive, public sector-led reform left managed care as the solution for cost control. And for a period it worked, largely because managed care organizations were able to both squeeze payments to ..
- [A 10-year-review (1998 - 2007) on 3449 cases of osteoporotic hip fractures: trend of hospitalization and inpatient costs]Zhi an Cheng
Department of Orthopedics, The Second Affiliated Hospital of Guangzhou Traditional Chinese Medicine University, Guangzhou 510120, China
Zhonghua Liu Xing Bing Xue Za Zhi 29:1128-31. 2008....
- Insights from a national survey into why substance abuse treatment units add prevention and outreach servicesRebecca Wells
Department of Health Policy and Administration, School of Public Health, University of North Carolina, Chapel Hill, North Carolina, USA
Subst Abuse Treat Prev Policy 1:21. 2006..Based on an ecological framework of organizational strategy, three categories of predictors were tested: (1) environmental, (2) unit-level, and (3) unit leadership...
- Modelling strategies for reducing pharmaceutical costs in hospitalC R Macintyre
Department of Public Health and Community Medicine, Westmead Hospital, New South Wales, Australia
Int J Qual Health Care 13:63-9. 2001..To describe drug utilization and cost in a large hospital and to compare the impact of different strategies on cost associated with drug prescribing...
- Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expendituresC S Dewa
Health Systems Research and Consulting Unit, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Clin Ther 23:292-306. 2001..In addition, SSRIs were one of the major contributors to the growth in psychotropic medication expenditures during the past 5 years...
- Toward meeting the challenge of physician competence assessment: the University of California, San Diego Physician Assessment and Clinical Education (PACE) ProgramWilliam A Norcross
UCSD PACE Program, Department of Family and Preventive Medicine, University of California, San Diego, School of Medicine, La Jolla, California 92093 8204, USA
Acad Med 84:1008-14. 2009..for measuring competence and performance, including in-practice measures, (2) collaborative networking of assessment programs, (3) cost control, and (4) continued development of remedial measures that correspond to assessment findings.
- Massachusetts' approach to universal coverage: high hopes and faulty economic logicDavid U Himmelstein
Department of Medicine, Cambridge Hospital Harvard Medical School, Cambridge, MA 02139, USA
Int J Health Serv 37:251-7. 2007..The legislation reflects a political calculus favoring private insurers, and ignores the imperative of cost control and the financial realities of cash-strapped families...
- [Ongoing health management control by cost monitoring through tracer indicators]H Villanueva
Escuela de Salud Publica, Universidad Nacional de Cordoba, Hospital Estatal Domingo Funes, Cordoba, Argentina
Rev Panam Salud Publica 10:405-12. 2001....
- Diversity-Oriented Synthesis of Novel Heterocyclic & Natural Product-Like LibraryMARVIN YU; Fiscal Year: 2009..Other cost control techniques such as "two birds with one stone"-type fluorous tagging/ cleavage, sharing common building blocks, ..
- Swedish Neuroscience Institute / NEXT ConsortiumJohn W Henson; Fiscal Year: 2013..Therefore, we will develop a set of performance metrics that will drive increases in data quality, efficiency, patient safety and cost control.
- MANAGED MENTAL HEALTH CARE & PATTERNS OF UTILIZATIONBarbara Dickey; Fiscal Year: 1990..These financial tools for cost control have received a great deal of research attention...
- ECONOMIC INFLUENCES (ESPECIALLY HMOS) ON CESAREANSA Tussing; Fiscal Year: 1990..The research will add significantly to the literature on provider-induced demand for medical care; health maintenance organizations; and the determinants of cesareans. It has cost-control, medical, and ethical implications...
- QUALITY OF LIFE IN HIV+ AND PRIMARY CARE PATIENTSJoel Tsevat; Fiscal Year: 1991..emphasize outcomes research, quality and effectiveness of care, technology assessment, practice guidelines, and cost control. Mortality data, while important, will not suffice: quality of life data will be pivotal...
- Oxygen Device For Persons With Respiratory DisabilityJOHN IZUCHUKWU; Fiscal Year: 2004..Healthcare reform and continuing cost control measures have limited patient therapeutic choices to low-cost modalities regardless of effectiveness...
- VOLUME RESPONSE TO MEDICARE FEE CUTS WITH MULTI-PAYERSMing Tai Seale; Fiscal Year: 1993Despite many cost control measures implemented in the 1980's, Medicare outlays to physicians continued to grow at double-digit rates...
- Optimal pricing of employer-based Health PlansCaroline Carlin; Fiscal Year: 2005..Most employers are driven by cost control, and want to create an incentive for employees to enroll in efficient plans...
- PHYSICIAN-INDUCED DEMAND--PRIVATE AND PUBLIC SECTORSCHIMAN YIP; Fiscal Year: 1993..If that is the case, then the intended goal of the MFS for cost control will be undermined...
- Ownership and Contracting for Quality Health CareRichard Zeckhauser; Fiscal Year: 2003..The second component will develop a theoretical framework for analyzing how premium payment systems interact with provider payment to affect quality, cost and access. ..
- CONFERENCE: BEHAVIORAL HEALTH WORK FORCE EDUCATIONMichael Hoge; Fiscal Year: 2002Over the past decade, a new paradigm in behavioral health care has emerged that emphasizes the following themes: cost control and cost effectiveness; evidence-based practice and the use of practice guidelines; patient safety; assessment ..
- PATIENT ADHERENCE AMONG CHRONIC DISEASE PATIENTSRONALD HAYS; Fiscal Year: 1990..b>Cost control mechanisms are unlikely to succeed unless rates of noncompliance are substantially lowered...
- Bariatric Surgery Outcome/Cost in Medicare BeneficiariesDavid Flum; Fiscal Year: 2006..at large, public reporting of postoperative deaths and complications at leading medical centers and because of cost control considerations...
- CORPORATIONS AND THE COST CONTAINMENT ISSUEHARVEY SAPOLSKY; Fiscal Year: 1980..of corporate action are explored - involvement in local health care planning and sponsorship interest in health maintenance organizations as a cost control device. The study employs elite interview and organizational analysis methodology.
- A GOAL PROGRAMMING MODEL FOR NURSING SERVICE BUDGETINGVANDANKUMAR TRIDEDI; Fiscal Year: 1980..The model provides a vehicle for cost control by objective decision making in a harmonious fashion with collaboration between a hospital's financial ..
- COMPUTER ASSISTED SUPPORT FOR UNDER-SERVED SMOKERSFREDERICK BOCK; Fiscal Year: 2001..An efficacy study will be used to examine the relative utility of this system compared to a low-cost control in an A-B-A design...
- The Spillover Effects of Health Insurance Coverage and GenerosityKatherine Baicker; Fiscal Year: 2008..unreadable] [unreadable] [unreadable]..
- NETWORK EFFECTS IN MENTAL HEALTH MANAGED CAREThomas McGuire; Fiscal Year: 2002..4) Test the behavior of the managed care plans against the predictions of the optimal network theory. ..
- Impact of Poor Health & AIDS on Small Businesses in SAMark Pauly; Fiscal Year: 2003..They will be useful for predicting the effect of changes in health on economic activity in this sector, and for allocating resources for disease prevention and treatment. ..
- Impact of the Medicare Part D Benzodiazepine Exclusion on Managed Care PatientsSusan Ettner; Fiscal Year: 2008..Our findings will inform the ongoing debate over amending Part D legislation to include BZD coverage by providing objective data to guide policymakers on the likely costs and benefits. [unreadable] [unreadable] [unreadable]..
- Treatment Patterns, Expenditures and Outcomes in MBHOsSusan Ettner; Fiscal Year: 2005..e., how psychotherapy visits are associated with outcomes and expenditures. Selection models will be used to estimate this relationship for patients with and without drug use. ..
- Economics of Formulary Design and Mental Health PolicyHaiden Huskamp; Fiscal Year: 2006..Huskamp the training, mentoring, time and resources to develop the skills that will put her in a position to lead independent research on the economics of pharmaceutical treatment for mental illnesses. ..
- Nursing Home IT: Optimal Medication and Care DeliverySusan Horn; Fiscal Year: 2006..Distill and summarize lessons learned about what is critical for successful implementation of HIT in nursing homes, including facilitators, barriers, and strategies to address them. ..
- Mental Health Spending and Quality of CareThomas G McGuire; Fiscal Year: 2010..Committee in June of 2007 suggested that the weak link between variation in spending and quality pointed toward cost control opportunities that will not affect outcomes...
- MH AND ADVERSE SELECTION IN MANAGED CAREThomas McGuire; Fiscal Year: 2001..Understanding how adverse selection works in managed care and what can be done about it should be a very high priority for research. ..
- Telemedicine-Based Collaborative Care to Reduce Rural Health DisparitiesJohn C Fortney; Fiscal Year: 2010..This population is at high risk for experiencing health disparities and thus, interventions targeting this population have the potential to have a major impact. ..
- Economics of Racial & Ethnic Disparities in MH ServicesThomas McGuire; Fiscal Year: 2005..Test for evidence that patient reaction to provider discrimination leads to lower compliance rates and worse outcomes for these minorities. ..
- Costs of Preventing Alcohol Problems in Older AdultsSusan Ettner; Fiscal Year: 2007..abstract_text> ..
- Effects of Mental Parity on High-Cost and Severely-Ill IndividualsHaiden A Huskamp; Fiscal Year: 2011..We will estimate a combination of two-part random-effects models for longitudinal data, latent class random-effects models, logistic regression models, Poisson regression models, and hazard models to address these aims. ..
- Comparative Effectiveness of Comprehensive Care for Adults with SMITODD PATRICK GILMER; Fiscal Year: 2010....
- Regionalizing Cancer SurgeryVivian Ho; Fiscal Year: 2007..The analyses will also serve as case studies to determine the value and feasibility of analyzing a wider range of surgeries using these methods. [unreadable] [unreadable] [unreadable]..
- Telephone Counseling: Men w/Prostate CA & PartnersTerry Badger; Fiscal Year: 2007..Data will be analyzed through descriptive statistics, a series of two-way mixed design ANOVAs and individual regression analyses. [unreadable] [unreadable] [unreadable]..
- Flow Instrument for Two-color Assay on MicrotranspondersWlodek Mandecki; Fiscal Year: 2007..The flow reader can be used for diagnostics in vitro and drug discovery projects. [unreadable] [unreadable] [unreadable]..
- How child welfare inter-agency cooperation may reduce youth HIV risk behaviorsRebecca Wells; Fiscal Year: 2007..These findings will inform managers of related health and social services.yield actionable guidance to child welfare agency managers and policy makers in allocating scarce resources. [unreadable] [unreadable] [unreadable]..
- Mechanisms and Moderators of Behavior Change in Alcoholics AnonymousJohn Kelly; Fiscal Year: 2008..unreadable] [unreadable] [unreadable]..
- Fractures, Heart Disease, and Stroke on Aromatase InhibitorsNancy L Keating; Fiscal Year: 2010....
- Informatics based nurse triage in lung transplant careStanley Finkelstein; Fiscal Year: 2008..unreadable] [unreadable]..
- Roots of Health Disparities: The Quality of Primary CarePeter Bach; Fiscal Year: 2008..The significance of these findings would be that a singular approach to improving the quality of care provided by physicians should enhance care quality overall and reduce healthcare disparities. ..
- Adoption of Buprenorphine in an HMO SettingDennis McCarty; Fiscal Year: 2009..Aim 3: Identify factors that facilitate and inhibit the adoption and use of buprenorphine through interviews with 530 patients and 96 practitioners and administrators. ..
- Improving Quality and Reducing Disparities: Complementary or Competing GoalsDavid Blumenthal; Fiscal Year: 2007..The Harvard interfaculty Program for Health Systems Improvement will be responsible for the planning and execution of the meeting. [unreadable] [unreadable] [unreadable]..
- Impact of Prior Approval for Antidepressants in MedicaidStephen Soumerai; Fiscal Year: 2007..All analyses will be stratified by type of disability (mental, physical, developmental). ..
- DEVELOPMENT OF A VACCINE FOR HUMAN PERIODONTITISROY PAGE; Fiscal Year: 2001..These observations will contribute in a major way to closing the gaps in our knowledge of the role of the host immune response in the pathogenesis of periodontitis. ..
- IMPROVING HEALTH BEHAVIOR AND OUTCOMES AFTER ANGIOPLASTYMary Charlson; Fiscal Year: 2002..abstract_text> ..
- CONSTRUCTING NEUROTROPHIN FIELDS IN THE BRAINW Saltzman; Fiscal Year: 2002..abstract_text> ..
- Exacerbation of Alzheimer's Disease by Nitrous OxideW Kofke; Fiscal Year: 2003..Moreover, observation of a protective effect may result in discovery of an easily implemented preventative drug therapy for AD. ..
- ESCAPE Mechanistic SubstudiesRobert Califf; Fiscal Year: 2003..Catecholamines are also being collected at baseline and 3 months. In addition, the ESCAPE investigators are all ready capturing detailed demographic, clinical, and physiological information as part of the protocol for the primary study. ..
- Mental Health and Labor Market OutcomesRoland Sturm; Fiscal Year: 2004....
- Reducing benzodiazepines and hip fracture in the elderlyStephen Soumerai; Fiscal Year: 2004..Phase II analyses will also contribute a novel method for evaluating health outcomes of changes in medication use in large populations. ..
- Cell-based Assay on MicrotranspondersWlodek Mandecki; Fiscal Year: 2004..The benefits of the program involve the advancement of cell-based assay technology, acceleration of drug discovery programs in research laboratories and pharmaceutical industry, and cost savings. ..
- Cost-Related Underuse of Medications in the ElderlyStephen Soumerai; Fiscal Year: 2006..unreadable] [unreadable]..
- Impact/HIV Intervention/Adolescent Males Leaving JailNicholas Freudenberg; Fiscal Year: 2005..This sub-study will also be used to tailor the intervention tested in this proposal for adolescent females. ..
- Adoption of Buphenorphine in Office PracticeSTANLEY WALLACK; Fiscal Year: 2006..abstract_text> ..
- Specialty Mental Health Care--Expanding Access in an HMODominic Hodgkin; Fiscal Year: 2003..The results will inform health plan decision-makers and others as they make utilization management choices that may have a major impact on patients and enrollee populations overall. ..
- LINKING OCCUPATIONAL INJURY AND ILLNESS DATA BASESKenneth Rosenman; Fiscal Year: 2002..We have assembled an interdisciplinary team consisting of an occupational health physician, epidemiologists, a biostatistician and a computer programmer. We have arranged access to all nine data systems. ..
- COST-EFFECTIVENESS ANALYSIS OF SURGERY IN EPILEPSY-CEASEJohn Langfitt; Fiscal Year: 2001..Identifying the most valid utilization and preference assessment methods will help future investigators make informed, data-based choices of measures for outcomes studies in patients with epilepsy and other chronic, neurologic diseases. ..
- A Randomized Trial of Home Self-Efficacy EnhancementAnthony Jerant; Fiscal Year: 2007..The findings will help policymakers, payers, and providers identify which interventions to implement. ..
- Analyzing Vaccine Programs/Policies in Western EuropeGary Freed; Fiscal Year: 2004..abstract_text> ..
- Modeling CJ Involvemment Among PMIWilliam Fisher; Fiscal Year: 2005....
- Selection and the Quality Impact of Nursing Home OwnershipDavid C Grabowski; Fiscal Year: 2010..By examining this relationship using a novel empirical strategy, this study provides an opportunity to improve the quality of care for the millions of Americans receiving care in the nursing home setting. ..
- Leveraging Medicare Payment & Reporting Policies to Improve Nursing Home QualityDavid C Grabowski; Fiscal Year: 2010..Thus, the information derived from this study has the potential to make important research and policy-relevant contributions aimed at improving the quality of care for all nursing home residents. ..